Pfizer have a collaboration with the Velasco team (Crizotinib). I am sure that they are very well informed about Cellmid's own collaboration with Complutense/Velasco and will be watching closely the midkine antibody development. Might be interesting both as a standalone and combinational therapy.
And it's good to see that the cannabinoid related studies continue, too.
CDY Price at posting:
47.5¢ Sentiment: Buy Disclosure: Held